Featured Research

from universities, journals, and other organizations

Treatment hope for muscular dystrophy

Date:
April 4, 2012
Source:
University of Melbourne
Summary:
Medical researchers have found that increasing a specific protein in muscles could help treat Duchenne muscular dystrophy, a severe and progressive muscle wasting disease that affects young boys.

An international team led by the University of Melbourne Australia, has found that increasing a specific protein in muscles could help treat Duchenne muscular dystrophy (DMD), a severe and progressive muscle wasting disease that affects young boys.

Related Articles


Approximately one in every 3,500 boys worldwide is afflicted with DMD. There is no cure for the disease which causes muscle fragility, spinal curvature and premature death.

Results from the studies recently published in Nature showed that by increasing levels of 'heat shock protein 72' (HSP72) in the muscles of animal models of DMD, muscle strength improved, the disease progression slowed and lifespan increased.

The research led by Professor Gordon Lynch, Head of the Department of Physiology at the University of Melbourne and conducted by Dr Stefan Gehrig for his PhD, investigated several scientific approaches of increasing the levels of the protein. The study was also performed in collaboration with Professor Mark Febbraio and his team at Baker IDI Heart and Diabetes Institute.

One approach revealed that administering the drug BGP-15 (which increases HSP72) improved overall muscle function in limbs and the diaphragm, a muscle critical for breathing. In addition, the lifespan increased by 20 per cent.

The researchers also discovered that increasing HSP72 in muscles improved the function of a pump responsible for controlling calcium levels confirming it as a target for future therapeutic drugs for the disease.

"Our studies show that by increasing HSP72, we can improve calcium pump function which could be a way to help reduce the muscle breakdown in boys suffering the condition," Professor Lynch said.

"We hope that these exciting findings will serve as the basis for future clinical trials within the next five to 10 years," Professor Lynch said.

Researchers from The University of Oxford, UK and Deakin University, Australia also collaborated in the research. The project was supported by the National Health and Medical Research Council, The Heart Foundation, Association Franηaise contre les Myopathies and the Muscular Dystrophy Association (USA). BGP-15 was provided by the pharmaceutical company N-Gene.


Story Source:

The above story is based on materials provided by University of Melbourne. Note: Materials may be edited for content and length.


Journal Reference:

  1. Stefan M. Gehrig, Chris van der Poel, Timothy A. Sayer, Jonathan D. Schertzer, Darren C. Henstridge, Jarrod E. Church, Severine Lamon, Aaron P. Russell, Kay E. Davies, Mark A. Febbraio, Gordon S. Lynch. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature, 2012; DOI: 10.1038/nature10980

Cite This Page:

University of Melbourne. "Treatment hope for muscular dystrophy." ScienceDaily. ScienceDaily, 4 April 2012. <www.sciencedaily.com/releases/2012/04/120404133757.htm>.
University of Melbourne. (2012, April 4). Treatment hope for muscular dystrophy. ScienceDaily. Retrieved April 22, 2015 from www.sciencedaily.com/releases/2012/04/120404133757.htm
University of Melbourne. "Treatment hope for muscular dystrophy." ScienceDaily. www.sciencedaily.com/releases/2012/04/120404133757.htm (accessed April 22, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 22, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Teva Offers $40 Billion for Mylan

Teva Offers $40 Billion for Mylan

Reuters - Business Video Online (Apr. 21, 2015) — Generic drugmaker Teva Pharmaceutical is offering $82 a share, or $40 billion, for its smaller rival Mylan, in an alternative to Mylan&apos;s deal to buy Perrigo. Bobbi Rebell reports. Video provided by Reuters
Powered by NewsLook.com
Blue Bell Recalls All Products

Blue Bell Recalls All Products

AP (Apr. 21, 2015) — Blue Bell Creameries voluntary recalled for all of its products after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria. Blue Bell&apos;s President and CEO issued a video statement. (April 21) Video provided by AP
Powered by NewsLook.com
Yemen Doctors at Breaking Point

Yemen Doctors at Breaking Point

Reuters - News Video Online (Apr. 21, 2015) — A Sanaa hospital struggles to cope with the high number of casualties with severe injuries, after an air strike left at least 25 dead and hundreds wounded. Deborah Lutterbeck reports. Video provided by Reuters
Powered by NewsLook.com
'Tutu Tuesdays' Brighten Faces at Kids' Hospital

'Tutu Tuesdays' Brighten Faces at Kids' Hospital

AP (Apr. 21, 2015) — Doctors and nurses have started wearing ballet tutus every Tuesday to cheer up young hospital patients at a Florida hospital. It started with a request made by a nervous patient -- now, almost the entire staff is wearing the tutus. (April 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins